Davis Polk & Wardwell and Conyers Dill & Pearman advised Roivant Sciences Ltd. on the offering. Cooley advised Immunovant on the transaction.Roivant Sciences Ltd. (Nasdaq:ROIV) announced a…
Roivant Sciences’ $200 Million Common Shares Offering


Davis Polk & Wardwell and Conyers Dill & Pearman advised Roivant Sciences Ltd. on the offering. Cooley advised Immunovant on the transaction.Roivant Sciences Ltd. (Nasdaq:ROIV) announced a…
…